Does TRT Affect Fertility? What Men Need to Know

Testosterone replacement therapy is one of the most effective treatments available for hypogonadism, but it comes with a fertility consequence that is frequently under-discussed: TRT suppresses the body's natural testosterone production and, with it, sperm production. For men who are currently trying to father children — or who want to preserve that option for the future — understanding this dynamic is not optional. It's essential. The good news is that fertility can often be preserved with the right approach from the start.

Understanding the HPG Axis: The Body's Testosterone Feedback Loop

To understand why TRT impairs fertility, you first need to understand the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal feedback loop that governs testosterone production in men. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses, which signals the anterior pituitary to secrete two critical hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

LH travels through the bloodstream to the testes, where it signals Leydig cells to produce testosterone. FSH acts on Sertoli cells within the testes to support spermatogenesis — the production of sperm. Both LH and FSH are absolutely required for healthy sperm production: LH drives intratesticular testosterone (which must reach concentrations 40–70 times higher than serum levels to support sperm maturation), while FSH directly stimulates the seminiferous tubules where sperm develop.

The system operates on negative feedback: when testosterone levels are adequate, the brain detects this and reduces GnRH, LH, and FSH output to maintain homeostasis. When testosterone is low, the opposite occurs — LH and FSH rise in an attempt to stimulate more production.

How TRT Shuts Down Sperm Production

When exogenous testosterone (from injections, gels, pellets, or patches) enters the bloodstream, the hypothalamus and pituitary detect elevated testosterone levels and respond by drastically reducing GnRH, LH, and FSH secretion. Without LH stimulation, Leydig cells in the testes stop producing testosterone. Without FSH, spermatogenesis slows and eventually halts.

This isn't an incidental side effect — testosterone itself has historically been studied as a male contraceptive for exactly this reason. World Health Organization studies in the 1990s confirmed that weekly testosterone injections suppressed sperm counts to below 3 million/mL (severe oligospermia) in approximately 70% of men and to azoospermia (no sperm) in about 30%, achieving contraceptive efficacy comparable to female oral contraceptives.

In clinical TRT practice, the timeline is typically: within 6–8 weeks of starting TRT, LH and FSH drop to near-undetectable levels. Testicular size begins to decrease as intratesticular testosterone drops and spermatogenesis stalls. By 3–6 months, sperm counts in many men approach azoospermia, though individual variation is significant. Some men maintain low but detectable sperm counts even on TRT; others experience complete suppression within weeks.

The testicular atrophy associated with TRT is not purely cosmetic — it reflects genuine suppression of the germ cell population within the seminiferous tubules. Severe or prolonged suppression can make recovery of fertility more challenging, underscoring why this conversation must happen before TRT begins for men with any fertility considerations.

Is TRT Fertility Suppression Reversible?

For most men, yes — fertility suppression from TRT is reversible after discontinuation, but recovery is neither guaranteed nor rapid. Published data suggest that most men recover sperm counts to pre-TRT levels within 6–18 months of stopping therapy, though the range of outcomes is wide. A 2015 review published in Fertility and Sterility analyzed 49 studies and found that sperm concentration recovered to baseline in 67% of men within 6 months and 90% within 24 months of stopping TRT.

However, "recovery" should not be taken as a promise. Several factors influence the likelihood and speed of fertility recovery:

• Duration of TRT: Longer durations of suppression (particularly beyond 2–3 years) are associated with slower and less complete recovery.
• Age: Older men (particularly over 40) may experience more prolonged suppression recovery due to reduced baseline gonadotropin reserve.
• Pre-existing fertility status: Men with underlying fertility issues before starting TRT may not recover to a functional level even after recovery appears complete on paper.
• Testicular size and function: Significant testicular atrophy during TRT may indicate more substantial damage to the spermatogenic apparatus.

For men planning to conceive, waiting 12–24 months after stopping TRT before concluding that fertility is impaired is typically recommended — and using fertility-preserving strategies from the outset is far preferable to trying to recover after the fact.

HCG: The Most Effective Fertility-Preservation Strategy During TRT

Human chorionic gonadotropin (HCG) is structurally similar to LH and binds to the same receptors on testicular Leydig cells. When administered alongside TRT, HCG essentially replaces the LH signal that TRT suppresses — stimulating ongoing intratesticular testosterone production, maintaining testicular volume, and supporting spermatogenesis.

This is the most well-validated fertility-preservation strategy for men on TRT. A pivotal study by Coviello et al. published in the Journal of Clinical Endocrinology & Metabolism in 2005 demonstrated that adding HCG (125–500 IU every other day) to TRT fully maintained intratesticular testosterone concentrations that would otherwise fall 94% below baseline on TRT alone. Men using this combination maintained testicular volume, sperm production, and measurable gonadotropin activity throughout TRT.

Typical HCG protocols alongside TRT use 500–1,500 IU subcutaneously two to three times per week. Some clinicians prefer a lower daily dose approach. The goal is to maintain intratesticular testosterone at levels sufficient to support ongoing spermatogenesis without supraphysiological elevation that could cause unwanted side effects (fluid retention, estrogen elevation).

HCG is also used for men who want to restart natural testosterone production after stopping TRT, often combined with a SERM protocol (described below) to accelerate the HPG axis recovery timeline from potentially 18+ months to 3–6 months.

Clomiphene Citrate and Enclomiphene: Fertility-Preserving TRT Alternatives

For men with hypogonadism who want to treat low testosterone without suppressing fertility, selective estrogen receptor modulators (SERMs) — specifically clomiphene citrate (Clomid) and its purified isomer enclomiphene — offer a compelling alternative to traditional TRT. Rather than replacing testosterone from an external source, these medications block estrogen receptors in the hypothalamus and pituitary, eliminating the negative feedback signal that suppresses GnRH, LH, and FSH.

The result: the brain "sees" lower effective estrogen levels and responds by increasing GnRH pulsatility, which stimulates LH and FSH secretion, which in turn drives the testes to produce more testosterone naturally. Critically, this approach raises testosterone through the normal HPG axis — meaning LH, FSH, intratesticular testosterone, and spermatogenesis are all maintained or enhanced.

Multiple RCTs support clomiphene as an effective testosterone restoration strategy. A study by Shabsigh et al. published in The Journal of Urology (2005) found that clomiphene 50 mg every other day raised testosterone from a mean of 247 ng/dL to 610 ng/dL while simultaneously increasing LH from 4.0 to 9.5 mIU/mL and FSH from 5.1 to 8.5 mIU/mL — all without suppression of fertility. Most patients also reported improvement in hypogonadal symptoms including energy, libido, and mood.

Enclomiphene (the trans-isomer of clomiphene) is considered the more active compound and has fewer of the estrogenic side effects associated with the other isomer (zuclomiphene). Multiple phase III trials demonstrated that enclomiphene maintained testosterone levels comparable to TRT injections while fully preserving sperm count and reproductive hormones — making it perhaps the ideal option for younger men who want testosterone benefits without fertility risk.

Sperm Banking: The Insurance Policy

For men who are beginning TRT and have any possibility of wanting biological children in the future, sperm cryopreservation (sperm banking) before starting TRT is strongly recommended. Sperm banking is a simple, low-cost procedure: a semen sample is collected, analyzed, and frozen at a fertility clinic or sperm bank. Stored correctly, frozen sperm can remain viable for decades.

The cost of sperm banking is typically $200–500 for the initial analysis and freezing, with annual storage fees of $100–300. Against the backdrop of the cost and emotional toll of fertility treatments, sperm banking is one of the most cost-effective "insurance policies" available in men's health.

Men should ideally bank sperm before starting any testosterone therapy. However, if a man has already been on TRT, it is worth attempting sperm banking after a recovery period — ideally after a structured HCG ± SERM restart protocol — even if the sample quality is reduced from pre-TRT levels.

What to Discuss With Your TRT Provider Before Starting

Before beginning TRT, every man of reproductive age should have an explicit conversation with his provider covering the following points:

Fertility intentions: Are you currently trying to conceive? Do you want the option in the next 2, 5, or 10 years? Even uncertainty about future fertility goals is a reason to take a fertility-preserving approach from the outset.

Alternative protocols: Depending on your clinical picture, alternatives to traditional TRT (HCG monotherapy, clomiphene/enclomiphene, anastrozole for estrogen management) may adequately address hypogonadal symptoms while preserving the HPG axis. These are underutilized options in many TRT practices.

Baseline semen analysis: A baseline semen analysis before starting TRT documents your starting fertility status and provides a reference point if questions arise later. This is particularly valuable if pre-existing fertility issues are suspected.

Monitoring plan: If you do start TRT, discuss the monitoring schedule for LH, FSH, and semen analysis if fertility preservation is important to you. Some providers add HCG prophylactically from day one for any patient of reproductive age.

At Truventa Medical, fertility considerations are a standard part of our TRT intake process for men under 50. We do not believe in a one-size-fits-all testosterone protocol, and we work to identify the approach that best matches both your symptom management goals and your reproductive future.